SHIM
ALT icon

Stone House Investment Management’s Altimmune ALT Stock Holding History

Stone House Investment Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6K Hold
526
– – ﹤0.01% 781
2026
Q1 		$1.62K Buy
526
+26
+5% +$110 ﹤0.01% 628
2025
Q4 		$1.8K Hold
500
– – ﹤0.01% 567
2025
Q3 		$1.89K Hold
500
– – ﹤0.01% 494
2025
Q2 		$1.94K Hold
500
– – ﹤0.01% 413
2025
Q1 		$2.5K Buy
+500
New +$3.17K ﹤0.01% 370
2024
Q4 		– Sell
-500
Closed -$3.07K – 65
2024
Q3 		$3.07K Hold
500
– – ﹤0.01% 310
2024
Q2 		$3.33K Hold
500
– – ﹤0.01% 304
2024
Q1 		$5.09K Buy
+500
New +$5.09K ﹤0.01% 288

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stone House Investment Management's ALT Position: Q2 2026 in Review

Stone House Investment Management held its Altimmune (ALT) position steady in Q2 2026 at 526 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #781.

Stone House Investment Management first reported a position in ALT in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.09K in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Stone House Investment Management held 526 shares of Altimmune worth $1.6K as of Q2 2026.
  • Stone House Investment Management left its Altimmune share count unchanged in Q2 2026.
  • Altimmune made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #781 holding.
  • Stone House Investment Management first reported a position in Altimmune in Q1 2024 and has held it in 9 quarters since.
  • Stone House Investment Management's Altimmune position peaked at $5.09K in Q1 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.